| Primary |
| Chronic Myeloid Leukaemia |
62.3% |
| Prophylaxis |
8.7% |
| Hypertension |
4.9% |
| Diabetes Mellitus |
4.6% |
| Gastrointestinal Stromal Tumour |
4.6% |
| Rash |
2.3% |
| Acute Lymphocytic Leukaemia |
1.8% |
| Pain |
1.7% |
| Acute Myeloid Leukaemia |
1.4% |
| Constipation |
1.3% |
| Cancer Pain |
1.0% |
| Oedema |
0.9% |
| Hypercholesterolaemia |
0.8% |
| Convulsion |
0.6% |
| Coronary Artery Disease |
0.6% |
| Cerebral Infarction |
0.5% |
| Chronic Myeloid Leukaemia Transformation |
0.5% |
| Dyspepsia |
0.5% |
| Headache |
0.5% |
| Nausea |
0.5% |
|
| Electrocardiogram Qt Prolonged |
9.8% |
| White Blood Cell Count Decreased |
8.9% |
| Vomiting |
8.4% |
| Myocardial Infarction |
8.0% |
| Thrombocytopenia |
7.6% |
| Rash |
7.1% |
| Stent Placement |
7.1% |
| Weight Decreased |
5.3% |
| Renal Impairment |
4.9% |
| White Blood Cell Count Increased |
4.9% |
| Pyrexia |
4.4% |
| Pneumonia |
4.0% |
| Vascular Graft |
3.1% |
| Platelet Count Decreased |
2.7% |
| Surgery |
2.7% |
| Syncope |
2.7% |
| Mental Disorder |
2.2% |
| Rash Erythematous |
2.2% |
| Sudden Death |
2.2% |
| Pancreatitis |
1.8% |
|
| Secondary |
| Chronic Myeloid Leukaemia |
62.9% |
| Prophylaxis |
9.8% |
| Diabetes Mellitus |
6.3% |
| Hypertension |
2.5% |
| Dry Eye |
2.3% |
| Insomnia |
2.3% |
| Constipation |
1.7% |
| Chronic Myeloid Leukaemia Transformation |
1.5% |
| Convulsion |
1.5% |
| Oedema |
1.4% |
| Gastrointestinal Stromal Tumour |
1.2% |
| Headache |
1.2% |
| Rash |
1.0% |
| Cerebral Infarction |
0.8% |
| Pancytopenia |
0.8% |
| Acute Lymphocytic Leukaemia |
0.7% |
| Back Pain |
0.6% |
| Gingivitis |
0.6% |
| Leukaemia |
0.6% |
| Chronic Sinusitis |
0.5% |
|
| Thoracic Cavity Drainage |
16.5% |
| Rash |
11.4% |
| Stent Placement |
10.8% |
| Vascular Graft |
9.2% |
| White Blood Cell Count Decreased |
7.3% |
| Weight Decreased |
4.7% |
| Electrocardiogram Qt Prolonged |
4.4% |
| Pneumonia |
4.4% |
| Thrombocytopenia |
4.4% |
| Mental Disorder |
3.2% |
| Peripheral Ischaemia |
2.5% |
| Pyrexia |
2.5% |
| Rash Erythematous |
2.5% |
| Rash Pruritic |
2.5% |
| Surgery |
2.5% |
| Ventricular Extrasystoles |
2.5% |
| Wound Infection |
2.5% |
| Platelet Count Decreased |
2.2% |
| Platelet Count Increased |
1.9% |
| Rash Papular |
1.9% |
|
| Interacting |
| Chronic Myeloid Leukaemia |
50.0% |
| Hypertension |
50.0% |
|
|
